Literature DB >> 20466560

Malignant pleural mesothelioma: the standard of care and challenges for future management.

Jan P van Meerbeeck1, Arnaud Scherpereel, Veerle F Surmont, Paul Baas.   

Abstract

This review addresses the management of MPM. In an introductory section, the etiology, epidemiology, presentation, diagnosis and staging of MPM will be reviewed. The evidence was collected by a systematic analysis of the literature (2000-2009) using the databases Medline (National Library of Medicine, USA), Embase (Elsevier, Netherlands), Cochrane Library (Great Britain), National Guideline Clearinghouse (USA), HTA Database (International Network of Agencies for Health Technology Assessment - INAHTA), NIH database (USA), International Pleural Mesothelioma Program - WHOLIS (WHO Database) with the following keywords and filters: pleura, cancer, mesothelioma, guidelines, treatment, surgery, chemotherapy, radiotherapy, palliation, supportive care, pleurodesis, review. 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20466560     DOI: 10.1016/j.critrevonc.2010.04.004

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  37 in total

1.  Joint modeling of multiple longitudinal patient-reported outcomes and survival.

Authors:  Laura A Hatfield; Mark E Boye; Bradley P Carlin
Journal:  J Biopharm Stat       Date:  2011-09       Impact factor: 1.051

2.  Biomarkers and prognostic factors for mesothelioma.

Authors:  Harvey I Pass
Journal:  Ann Cardiothorac Surg       Date:  2012-11

Review 3.  Radical multimodality therapy for malignant pleural mesothelioma.

Authors:  Omar Abdel-Rahman; Zeinab Elsayed; Hadeer Mohamed; Mostafa Eltobgy
Journal:  Cochrane Database Syst Rev       Date:  2018-01-08

4.  A Phase II Study of Pazopanib in Patients with Malignant Pleural Mesothelioma: NCCTG N0623 (Alliance).

Authors:  Kaushal Parikh; Sumithra J Mandrekar; Katie Allen-Ziegler; Brandt Esplin; Angelina D Tan; Benjamin Marchello; Alex A Adjei; Julian R Molina
Journal:  Oncologist       Date:  2019-12-24

Review 5.  Medical treatment of mesothelioma: anything new?

Authors:  Nagio Takigawa; Katsuyuki Kiura; Takumi Kishimoto
Journal:  Curr Oncol Rep       Date:  2011-08       Impact factor: 5.075

6.  SEOM guidelines for the treatment of malignant pleural mesothelioma.

Authors:  Pilar Lianes; Jordi Remon; Isabel Bover; Dolores Isla
Journal:  Clin Transl Oncol       Date:  2011-08       Impact factor: 3.405

Review 7.  MicroRNAs in mesothelioma: from tumour suppressors and biomarkers to therapeutic targets.

Authors:  Glen Reid
Journal:  J Thorac Dis       Date:  2015-06       Impact factor: 2.895

8.  Estimating the incidence of malignant mesothelioma in Vietnam: a pilot descriptive cancer registration study.

Authors:  Matthew J Soeberg; Mai Anh Luong; Van Thuan Tran; Anh Thanh Tran; Thị Thu Huyen Nguyen; Dieu Bui; Thi Hoai Nga Nguyen; Ken Takahashi; Nico van Zandwijk
Journal:  Int J Occup Environ Health       Date:  2016-07-08

9.  MiR-score: a novel 6-microRNA signature that predicts survival outcomes in patients with malignant pleural mesothelioma.

Authors:  Michaela B Kirschner; Yuen Yee Cheng; Nicola J Armstrong; Ruby C Y Lin; Steven C Kao; Anthony Linton; Sonja Klebe; Brian C McCaughan; Nico van Zandwijk; Glen Reid
Journal:  Mol Oncol       Date:  2014-12-02       Impact factor: 6.603

10.  PTEN protein expression in malignant pleural mesothelioma.

Authors:  Vijay Agarwal; Anne Campbell; Kate L Beaumont; Lynn Cawkwell; Michael J Lind
Journal:  Tumour Biol       Date:  2012-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.